CN113786459A - 一种用于心脑血管疾病的药物组合物及其制备方法与用途 - Google Patents
一种用于心脑血管疾病的药物组合物及其制备方法与用途 Download PDFInfo
- Publication number
- CN113786459A CN113786459A CN202111154481.8A CN202111154481A CN113786459A CN 113786459 A CN113786459 A CN 113786459A CN 202111154481 A CN202111154481 A CN 202111154481A CN 113786459 A CN113786459 A CN 113786459A
- Authority
- CN
- China
- Prior art keywords
- parts
- pharmaceutical composition
- cerebrovascular diseases
- cardiovascular
- treating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000002526 effect on cardiovascular system Effects 0.000 title claims abstract description 39
- 239000008194 pharmaceutical composition Substances 0.000 title claims abstract description 38
- 208000024172 Cardiovascular disease Diseases 0.000 title claims abstract description 35
- 208000026106 cerebrovascular disease Diseases 0.000 title claims abstract description 35
- 238000002360 preparation method Methods 0.000 title abstract description 19
- 239000008187 granular material Substances 0.000 claims abstract description 39
- 239000002994 raw material Substances 0.000 claims abstract description 21
- 244000220503 Persea thunbergii Species 0.000 claims abstract description 15
- 235000004267 Persea thunbergii Nutrition 0.000 claims abstract description 15
- 241001080798 Polygala tenuifolia Species 0.000 claims abstract description 15
- 241000045403 Astragalus propinquus Species 0.000 claims abstract description 14
- 244000042430 Rhodiola rosea Species 0.000 claims abstract description 14
- 235000003713 Rhodiola rosea Nutrition 0.000 claims abstract description 14
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 claims abstract description 14
- 241000304195 Salvia miltiorrhiza Species 0.000 claims abstract description 14
- 235000006533 astragalus Nutrition 0.000 claims abstract description 14
- 241000007126 Codonopsis pilosula Species 0.000 claims abstract description 13
- 244000124209 Crocus sativus Species 0.000 claims abstract description 13
- 235000015655 Crocus sativus Nutrition 0.000 claims abstract description 13
- 240000006509 Gynostemma pentaphyllum Species 0.000 claims abstract description 13
- 235000002956 Gynostemma pentaphyllum Nutrition 0.000 claims abstract description 13
- 241000244365 Ligusticum sinense Species 0.000 claims abstract description 13
- 244000131316 Panax pseudoginseng Species 0.000 claims abstract description 13
- 235000003181 Panax pseudoginseng Nutrition 0.000 claims abstract description 13
- 241000270666 Testudines Species 0.000 claims abstract description 13
- 241000305491 Gastrodia elata Species 0.000 claims abstract description 9
- 235000001287 Guettarda speciosa Nutrition 0.000 claims abstract description 4
- 235000013974 saffron Nutrition 0.000 claims abstract description 4
- 239000004248 saffron Substances 0.000 claims abstract description 4
- 244000061520 Angelica archangelica Species 0.000 claims abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 23
- 239000003814 drug Substances 0.000 claims description 21
- 238000001035 drying Methods 0.000 claims description 13
- 238000000227 grinding Methods 0.000 claims description 11
- 229940079593 drug Drugs 0.000 claims description 10
- 239000000843 powder Substances 0.000 claims description 10
- 238000002791 soaking Methods 0.000 claims description 9
- 239000002245 particle Substances 0.000 claims description 8
- 238000007789 sealing Methods 0.000 claims description 7
- 238000010438 heat treatment Methods 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- 238000004806 packaging method and process Methods 0.000 claims description 6
- 230000001954 sterilising effect Effects 0.000 claims description 6
- 238000005303 weighing Methods 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 5
- 241000213006 Angelica dahurica Species 0.000 claims 2
- 230000000694 effects Effects 0.000 abstract description 22
- 210000002216 heart Anatomy 0.000 abstract description 14
- 239000000203 mixture Substances 0.000 abstract description 4
- 231100000331 toxic Toxicity 0.000 abstract description 4
- 230000002588 toxic effect Effects 0.000 abstract description 4
- 210000004556 brain Anatomy 0.000 abstract description 2
- 230000004044 response Effects 0.000 abstract description 2
- 208000002193 Pain Diseases 0.000 description 18
- 230000036407 pain Effects 0.000 description 18
- 239000008280 blood Substances 0.000 description 14
- 210000004369 blood Anatomy 0.000 description 14
- 230000001737 promoting effect Effects 0.000 description 13
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
- 210000004185 liver Anatomy 0.000 description 10
- 201000010099 disease Diseases 0.000 description 9
- 210000004072 lung Anatomy 0.000 description 9
- 208000010125 myocardial infarction Diseases 0.000 description 9
- 241000382455 Angelica sinensis Species 0.000 description 8
- 206010011224 Cough Diseases 0.000 description 8
- 230000017531 blood circulation Effects 0.000 description 8
- 235000009508 confectionery Nutrition 0.000 description 8
- 235000019640 taste Nutrition 0.000 description 8
- 208000004998 Abdominal Pain Diseases 0.000 description 7
- 201000000736 Amenorrhea Diseases 0.000 description 7
- 206010001928 Amenorrhoea Diseases 0.000 description 7
- 231100000540 amenorrhea Toxicity 0.000 description 7
- 210000000952 spleen Anatomy 0.000 description 7
- 208000031971 Yin Deficiency Diseases 0.000 description 6
- 208000014674 injury Diseases 0.000 description 6
- 206010007247 Carbuncle Diseases 0.000 description 5
- 206010062717 Increased upper airway secretion Diseases 0.000 description 5
- 206010033557 Palpitations Diseases 0.000 description 5
- 206010042674 Swelling Diseases 0.000 description 5
- 208000026435 phlegm Diseases 0.000 description 5
- 230000008961 swelling Effects 0.000 description 5
- 230000008736 traumatic injury Effects 0.000 description 5
- 241000756943 Codonopsis Species 0.000 description 4
- 206010010774 Constipation Diseases 0.000 description 4
- 208000005171 Dysmenorrhea Diseases 0.000 description 4
- 206010013935 Dysmenorrhoea Diseases 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 208000019255 Menstrual disease Diseases 0.000 description 4
- 206010037660 Pyrexia Diseases 0.000 description 4
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 4
- AIGAZQPHXLWMOJ-UHFFFAOYSA-N Tanshinone I Chemical compound C1=CC2=C(C)C=CC=C2C(C(=O)C2=O)=C1C1=C2C(C)=CO1 AIGAZQPHXLWMOJ-UHFFFAOYSA-N 0.000 description 4
- 206010000891 acute myocardial infarction Diseases 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 206010022437 insomnia Diseases 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 206010002383 Angina Pectoris Diseases 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 208000001431 Psychomotor Agitation Diseases 0.000 description 3
- 206010038743 Restlessness Diseases 0.000 description 3
- 208000006011 Stroke Diseases 0.000 description 3
- 208000029078 coronary artery disease Diseases 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 201000004792 malaria Diseases 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000002689 soil Substances 0.000 description 3
- 230000002936 tranquilizing effect Effects 0.000 description 3
- 206010000077 Abdominal mass Diseases 0.000 description 2
- 241000125175 Angelica Species 0.000 description 2
- 241000208173 Apiaceae Species 0.000 description 2
- 241000271309 Aquilaria crassna Species 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 2
- 244000020518 Carthamus tinctorius Species 0.000 description 2
- 206010007882 Cellulitis Diseases 0.000 description 2
- 206010008190 Cerebrovascular accident Diseases 0.000 description 2
- 206010008479 Chest Pain Diseases 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 241000207923 Lamiaceae Species 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241000180649 Panax notoginseng Species 0.000 description 2
- 235000003143 Panax notoginseng Nutrition 0.000 description 2
- 208000031481 Pathologic Constriction Diseases 0.000 description 2
- 208000000418 Premature Cardiac Complexes Diseases 0.000 description 2
- 229930183118 Tanshinone Natural products 0.000 description 2
- 201000001943 Tricuspid Valve Insufficiency Diseases 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 230000036770 blood supply Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 230000002490 cerebral effect Effects 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 208000017574 dry cough Diseases 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 208000018997 giddiness Diseases 0.000 description 2
- 208000019622 heart disease Diseases 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 208000013403 hyperactivity Diseases 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 235000019633 pungent taste Nutrition 0.000 description 2
- 230000036262 stenosis Effects 0.000 description 2
- 208000037804 stenosis Diseases 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 208000031091 Amnestic disease Diseases 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 241000208340 Araliaceae Species 0.000 description 1
- 206010003211 Arteriosclerosis coronary artery Diseases 0.000 description 1
- 208000014644 Brain disease Diseases 0.000 description 1
- 241000208671 Campanulaceae Species 0.000 description 1
- 206010069729 Collateral circulation Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241000220284 Crassulaceae Species 0.000 description 1
- GVKKJJOMQCNPGB-JTQLQIEISA-N Cryptotanshinone Chemical compound O=C1C(=O)C2=C3CCCC(C)(C)C3=CC=C2C2=C1[C@@H](C)CO2 GVKKJJOMQCNPGB-JTQLQIEISA-N 0.000 description 1
- GVKKJJOMQCNPGB-UHFFFAOYSA-N Cryptotanshinone Natural products O=C1C(=O)C2=C3CCCC(C)(C)C3=CC=C2C2=C1C(C)CO2 GVKKJJOMQCNPGB-UHFFFAOYSA-N 0.000 description 1
- 241000219104 Cucurbitaceae Species 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010013887 Dysarthria Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000220485 Fabaceae Species 0.000 description 1
- 241000234271 Galanthus Species 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 239000009636 Huang Qi Substances 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 241001113425 Iridaceae Species 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 241000234280 Liliaceae Species 0.000 description 1
- 206010028372 Muscular weakness Diseases 0.000 description 1
- NEEQFPMRODQIKX-REOHCLBHSA-N N(3)-oxalyl-L-2,3-diaminopropionic acid Chemical group OC(=O)[C@@H](N)CNC(=O)C(O)=O NEEQFPMRODQIKX-REOHCLBHSA-N 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 244000248557 Ophiopogon japonicus Species 0.000 description 1
- 241000233855 Orchidaceae Species 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 235000014676 Phragmites communis Nutrition 0.000 description 1
- 241000208977 Polygalaceae Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 206010038084 Rectocele Diseases 0.000 description 1
- 241000997135 Rhodiola crenulata Species 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 206010042434 Sudden death Diseases 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 241001534930 Thymelaeaceae Species 0.000 description 1
- 206010044302 Tracheitis Diseases 0.000 description 1
- 206010044334 Trance Diseases 0.000 description 1
- 206010044640 Tricuspid valve incompetence Diseases 0.000 description 1
- 241001482311 Trionychidae Species 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000006986 amnesia Effects 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 229940126676 complementary medicines Drugs 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 208000026758 coronary atherosclerosis Diseases 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 229940126534 drug product Drugs 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 208000010515 dystocia Diseases 0.000 description 1
- 238000011841 epidemiological investigation Methods 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 229930182486 flavonoid glycoside Natural products 0.000 description 1
- 150000007955 flavonoid glycosides Chemical class 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 229930187479 gypenoside Natural products 0.000 description 1
- ZRBFCAALKKNCJG-UHFFFAOYSA-N gypenoside-XVII Natural products C1CC(C2(CCC3C(C)(C)C(OC4C(C(O)C(O)C(CO)O4)O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC(C(C(O)C1O)O)OC1COC1OC(CO)C(O)C(O)C1O ZRBFCAALKKNCJG-UHFFFAOYSA-N 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 229930195208 isotanshinone Natural products 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000036473 myasthenia Effects 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000001314 paroxysmal effect Effects 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 208000026473 slurred speech Diseases 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 229930189533 tanshinol Natural products 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/83—Thymelaeaceae (Mezereum family), e.g. leatherwood or false ohelo
- A61K36/835—Aquilaria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/586—Turtles; Tortoises, e.g. terrapins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/344—Codonopsis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/41—Crassulaceae (Stonecrop family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/424—Gynostemma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/69—Polygalaceae (Milkwort family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8968—Ophiopogon (Lilyturf)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8988—Gastrodia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/15—Preparation or pretreatment of starting material involving mechanical treatment, e.g. chopping up, cutting or grinding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种用于心脑血管疾病的药物组合物及其制备方法与用途,该药物组合物的原料包含:棋楠、当归、党参、黄芪、天麻、藏红花、丹参、红景天、远志、麦冬、绞股蓝、鳖甲、三七、川穹。本发明还提供了该药物组合物的用途,该药物组合物用于制备心脑血管疾病患者服用的冲剂。本发明还提供了该冲剂的制备方法。本发明提供的用于心脑血管疾病的药物组合物及其制备方法与用途,该药物组合物具有组方合理、用量少、效果显著、无毒副作用、迅速起效等特点,制备的冲剂可用于各类心脑血管疾病的治疗或预防,或用于急救心脑突发性的情况。
Description
技术领域
本发明涉及一种药物组合物及其制备方法与用途,具体地,涉及一种用于心脑血管疾病的药物组合物及其制备方法与用途。
背景技术
随着经济社会的发展,人们的生活方式的改变,导致心血管的发病率逐年增加,心血管死亡占城乡居民走死亡原因的首位,而每年死于心血管疾病的人数中就有一半以上死于心肌梗死。据相关数据统计,近些年来心梗造成的死亡率大幅提升,突发性的心梗死亡率高达11.9%,已经成为除癌症外致死率最高的一大病症。
近年来的流行病学调查表明,中国人心肌梗死的发病率大约在55/100000,世界人口的发病率大约在65/100000。我国每年大约有350万人死于心脑血管疾病,其中心梗人数大约占250万。且从患者的年龄趋势看,现如今的心梗患者不断的年轻化,年轻群体开始占据综合发病率的20%以上。总体而言,中国急性心肌梗死城市的发病率高于农村,男性的发病率高于女性。因为急性心肌梗死是一个高度危险甚至会猝死的疾病,所以大部分人发病之后都必须住院治疗,因此,我国每年用于治疗心肌梗死的费用也相当的高。
近年来心肌梗死发病率还在逐渐升高,急性心肌梗死原因是因为冠状动脉粥样硬化,造成一支或者多支血管官腔狭窄出现心肌供血不足,而此时侧支循环又未充分建立,在此基础上一旦血供急剧减少或者中断,会使得心肌严重而持久的缺血缺氧达到20-30分钟以上,就会发生急性心肌梗死,但之前很多患者却没有发作的预兆。而目前市场上也还没有具备有效的急救和预防保健的功能的药物产品,缺乏治疗和保健的特效药。
发明内容
本发明的目的是提供一种药物组合物及其制备方法与用途,用于心脑血管疾病,能够解决现有问题,具有保健的功能和显著的疗效,可以减轻患者痛苦,挽救患者生命健康。
为了达到上述目的,本发明提供了一种用于心脑血管疾病的药物组合物,其中,该药物组合物的原料包含:棋楠、当归、党参、黄芪、天麻、藏红花、丹参、红景天、远志、麦冬、绞股蓝、鳖甲、三七、川穹。
上述的用于心脑血管疾病的药物组合物,其中,所述的原料按重量份数计包含:棋楠200~300份、当归20~40份、党参10~30份、黄芪20~40份、天麻10~30份、藏红花5~15份、丹参40~60份、红景天10~30份、远志10~15份、麦冬10~15份、绞股蓝25~30份、鳖甲10~30份、三七20~40份、川穹40~60份。
上述的用于心脑血管疾病的药物组合物,其中,所述的原料按重量计包含:棋楠2500g、当归300g、党参200g、黄芪300g、天麻200g、藏红花100g、丹参500g、红景天200g、远志120g、麦冬120g、绞股蓝260g、鳖甲200g、三七300g、川穹500g。
本发明还提供了上述的用于心脑血管疾病的药物组合物的用途,其中,所述的药物组合物用于制备心脑血管疾病患者服用的冲剂。
本发明还提供了上述的冲剂的制备方法,其中,所述的方法为:按比例称量各药物,将各原料研磨破碎成粉末,然后加水浸泡,并加热萃取,再将药液通过浓缩提纯去除水分,干燥得到药物颗粒,最后密封包装灭菌,作为冲剂使用。
上述的冲剂的制备方法,其中,所述的研磨破碎的粒度范围为30~40目。
上述的冲剂的制备方法,其中,所述的加水浸泡的时间为24小时或以上。
上述的冲剂的制备方法,其中,所述的冲剂采用温水冲服。
本发明提供的用于心脑血管疾病的药物组合物及其制备方法与用途具有以下优点:
本发明是将各药物原料加工后合剂成散,可以用于有效地治疗心脑血管堵塞、心绞痛、冠心病、早博、二尖瓣三尖瓣反流狭窄、颈动脉斑块、中风、脑淤血等诸多脑血管和心脏相关疾病,并能预防缓解各类心脏和脑部疾病,或用于急救心脑突发性病况。
具体实施方式
以下对本发明的具体实施方式作进一步地说明。
本发明提供的用于心脑血管疾病的药物组合物,该药物组合物的原料包含:棋楠、当归、党参、黄芪、天麻、藏红花、丹参、红景天、远志、麦冬、绞股蓝、鳖甲、三七、川穹。
棋楠即奇楠,是沉香的中的一种,又叫伽南香,别名奇南香、琪喃等。伽喃香为瑞香科植物沉香或白木香含有沉香树脂的沉香木。具有理气,止痛,通窍的功效。治胸闷不舒,气滞疼痛,风痰闭塞。功胜沉香。
当归为伞形科植物当归的干燥根。秋末采挖,除尽芦头、须根,待水分稍行蒸发后按大小粗细分别捆成小把,用微火缓缓熏干或用硫黄烟熏,防蛀防霉切片生用,或经酒拌、酒炒用。味甜,微苦,略有麻舌感,味甘、辛,性温。归肝、心、脾经。具有补血活血、调经止痛、润肠通便、抗癌、抗老防老、免疫的功效的功效。主治血虚萎黄,眩晕心悸,月经不调,经闭痛经,虚寒腹痛,风湿痹痛,跌扑损伤,痈疽疮疡,肠燥便秘。可用于活血化瘀、通便。
党参为桔梗科植物党参、素花党参、或川党参等的干燥根。性味甘、平,补中益气、和胃生津、祛痰止咳,用于脾虚食少便溏、四肢无力、心悸、气短、口干、自汗、脱肛、阴挺,以及补元气。
黄芪为豆科植物蒙古黄芪的根。春、秋季采挖,除去泥土、须根及根头,晒至六七成干,理直扎捆后晒干。性味甘、微温,归肺、脾、肝、肾经,具有增强机体免疫功能、保肝、利尿、抗衰老、抗应激、降压和较广泛的抗菌作用,可用于增加免疫力。
天麻为兰科植物天麻的干燥块茎。性味甘、平,入肝经,具有息风、定惊的功效,主治眩晕眼黑、头风头痛、肢体麻木、半身不遂、语言蹇涩、小儿惊痫动风等,可用于四肢麻木。
藏红花为鸢尾科植物番红花花柱的上部及柱头。9~10月选晴天早晨采收花朵,摘下柱头,烘干,即为干红花。若再加工,使油润光亮,则为湿红花。以干红花品质较佳。置阴凉干燥处,密闭保存。味甘微酸,性平温,无毒。入心、肝经。具有活血化瘀,散郁开结的功效。主治忧思郁结,胸膈痞闷,吐血,伤寒发狂,惊怖恍惚,妇女经闭,产后瘀血腹痛,跌扑肿痛。
丹参为唇形科植物丹参的干燥根和根茎。味苦,微寒。归心、肝经。春、秋两季采挖,除去茎叶,洗净,润透,切成厚片,晒干。具有活血祛瘀,通经止痛,清心除烦,凉血消痈的功效。用于胸痹心痛,脘腹胁痛,瘕瘕积聚,热痹疼痛,心烦不眠,月经不调,痛经经闭,疮疡肿痛。丹参提取物为棕红色的粉末,是唇形科植物丹参的干燥根及根茎提取物,含有丹参酮、隐丹参酮、异丹参酮、丹参新酮、丹参醇等生物活性物质,同时还含有维生素A、E及铁、钾等金属元素。丹参酮具有雌性激素样功能,雌性激素可使皮脂腺缩小而减少皮脂分泌。性味苦,微寒;归心、心包、肝经。具有活血调经,祛瘀止痛,凉血消痈,除烦安神的功效。主治月经不调,闭经痛经,产后瘀滞腹痛,血瘀心痛,脘腹疼痛,癥瘕积聚,跌打损伤,风湿痹证,疮痈肿毒,热病烦躁神昏,心悸失眠。
红景天为景天科植物红景天或大花红景天的根茎。性味甘,寒;归脾、肺经。野生或栽培,秋季采挖,洗净,晒干,切段,生用。具有健脾益气,清肺止咳,活血化瘀的功效。主治脾气虚证,肺阴虚、肺热咳嗽。
远志为远志科植物细叶远志的根。春季出苗前或秋季地上部分枯萎后挖取根部,除去残基及泥土,阴干或晒干。趁新鲜时,选择较粗的根用木棒搂松或用手搓揉。味酸微辛,性平。入心、肾经。具有安神益智,祛痰,解郁的功效。主治惊悸,健忘,梦遗,失眠,咳嗽多痰,痈疽疮肿。
麦冬为百合科植物麦冬(沿阶草)的干燥块根。性味甘,微苦,微寒。归心、肺、胃经。用于肺胃阴虚之津少口渴、干咳咯血;心阴不足之心悸易惊及热病后期热伤津液等证。有养阴润肺、益胃生津、清心除烦的功效,主治肺燥干咳、阴虚痨嗽、喉痹咽痛、津伤口渴、内热消渴、心烦失眠、肠燥便秘等症,可用于润肺。
绞股蓝为葫芦科植物绞股蓝的全草。产于安徽、浙江、江西、福建、广东、贵州。现各地多有栽培。生于山间阴湿处。秋季采收,晒干。性寒,味苦。其主要有效成分是绞股蓝皂甙,此外还含有甾醇类、黄酮类成分,以及维生素C、谷氨酸等17种氨基酸和铁、锌、铜等18种微量元素。具有清热解毒、止咳清肺祛痰、养心安神、补气生精之功效,可用于降血压、降血脂、护肝、促进睡眠以及肠胃炎、气管炎、咽喉炎的治疗,并用于多种癌症的抗癌临床治疗。
鳖甲为鳖科动物鳖的背甲。全年均可捕捉,以秋、冬二季为多,捕捉后杀死,置沸水中烫至背甲上的硬皮能剥落时,取出,剥取背甲,除去残肉,晒干。分布于等地。味咸,性微寒。归肝、肾经。具有滋阴潜阳,退热除蒸,软坚散结之功效。常用于阴虚发热,骨蒸劳热,阴虚阳亢,头晕目眩,虚风内动,经闭,癥瘕,久疟疟母。
三七为五加科植物三七的干燥根。夏末秋初开花前或冬季种子成熟后采挖,去尽泥土,洗净,晒干。生用或研细粉用。主要含皂苷、黄酮苷、氨基酸等。止血活性成分为三七氨酸。性味甘、微苦,温;归肝、胃经。具有化瘀止血,活血定痛的功效。主治出血证,跌打损伤,瘀血肿痛。
川芎为伞形科植物川芎的干燥根茎;5月采挖,除去泥沙,晒后烘干,再去须根。用时切片生用或酒炙功效为行气开郁、法风燥湿、活血止痛;主治风冷头痛眩晕、胁痛腹疼、寒痹筋挛、经闭、难产、产后瘀阻块痛、痈疽疮疡。用于月经不调、经闭痛经、瘕腹痛、胸胁刺痛、跌扑肿痛、头痛、风湿痹痛。
优选地,该原料按重量份数计包含:棋楠200~300份、当归20~40份、党参10~30份、黄芪20~40份、天麻10~30份、藏红花5~15份、丹参40~60份、红景天10~30份、远志10~15份、麦冬10~15份、绞股蓝25~30份、鳖甲10~30份、三七20~40份、川穹40~60份。
更优选地,该原料按重量计包含:棋楠2500g、当归300g、党参200g、黄芪300g、天麻200g、藏红花100g、丹参500g、红景天200g、远志120g、麦冬120g、绞股蓝260g、鳖甲200g、三七300g、川穹500g。
各原料均采用野生中草药材,多年生的采用五年或以上的药材。取材自野生动物的,在条件不允许的情况下可以采用取自人工养殖动物的材料,或其他等效的替代物。
本发明还提供了该用于心脑血管疾病的药物组合物的用途,该药物组合物用于制备心脑血管疾病患者服用的冲剂。
本发明还提供了该冲剂的制备方法,该方法为:按比例称量各药物,将各原料研磨破碎成粉末,然后加水浸泡,并加热萃取,再将药液通过浓缩提纯去除水分,干燥得到药物颗粒,最后密封包装灭菌,作为冲剂使用。
优选地,研磨破碎的粒度范围为30~40目。加水浸泡的时间为24小时或以上。该冲剂采用温水冲服。
下面结合实施例对本发明提供的用于心脑血管疾病的药物组合物及其制备方法与用途做更进一步描述。
实施例1
一种用于心脑血管疾病的药物组合物,该药物组合物的原料按重量计包含:棋楠2500g、当归300g、党参200g、黄芪300g、天麻200g、藏红花100g、丹参500g、红景天200g、远志120g、麦冬120g、绞股蓝260g、鳖甲200g、三七300g、川穹500g。
本实施例还提供了该用于心脑血管疾病的药物组合物的用途,该药物组合物用于制备心脑血管疾病患者服用的冲剂。
本实施例还提供了该冲剂的制备方法,按比例称量各药物,将各原料研磨破碎成粉末,研磨破碎的粒度范围为30~40目。再加水浸泡,时间为24小时或以上。然后加热萃取,并将药液通过浓缩提纯去除水分,干燥得到药物颗粒,最后密封包装灭菌,作为冲剂使用。该冲剂采用温水冲服。
实施例2
一种用于心脑血管疾病的药物组合物,该药物组合物的原料按重量计包含:棋楠300g、当归40g、党参30g、黄芪40g、天麻30g、藏红花15g、丹参60g、红景天30g、远志15g、麦冬15g、绞股蓝30g、鳖甲30g、三七40g、川穹60g。
本实施例还提供了该用于心脑血管疾病的药物组合物的用途,该药物组合物用于制备心脑血管疾病患者服用的冲剂。
本实施例还提供了该冲剂的制备方法,按比例称量各药物,将各原料研磨破碎成粉末,研磨破碎的粒度范围为30~40目。再加水浸泡,时间为24小时或以上。然后加热萃取,并将药液通过浓缩提纯去除水分,干燥得到药物颗粒,最后密封包装灭菌,作为冲剂使用。该冲剂采用温水冲服。
实施例3
一种用于心脑血管疾病的药物组合物,该药物组合物的原料按重量计包含:棋楠2000g、当归200g、党参100g、黄芪200g、天麻100g、藏红花50g、丹参400g、红景天100g、远志100g、麦冬100g、绞股蓝250g、鳖甲100g、三七200g、川穹400g。
本实施例还提供了该用于心脑血管疾病的药物组合物的用途,该药物组合物用于制备心脑血管疾病患者服用的冲剂。
本实施例还提供了该冲剂的制备方法,按比例称量各药物,将各原料研磨破碎成粉末,研磨破碎的粒度范围为30~40目。再加水浸泡,时间为24小时或以上。然后加热萃取,并将药液通过浓缩提纯去除水分,干燥得到药物颗粒,最后密封包装灭菌,作为冲剂使用。该冲剂采用温水冲服。
各实施例中采用的原料分别符合相应的国家标准。
采用各实施例制备的冲剂进行临床试用,证明该药物组合物有明显效果。
该药物组合物具有组方合理、用量少、效果显著、无毒副作用、迅速起效等特点,可以用于有效地治疗和预防心脑血管堵塞、心绞痛、冠心病、早博、二尖瓣三尖瓣反流狭窄、颈动脉斑块、中风、脑淤血等诸多脑血管和心脏疾病,或者用于急救心脑突发性病况。所得的药物冲剂又名化淤至宝散(归甲颗粒)。
本发明提供的用于心脑血管疾病的药物组合物及其制备方法与用途,经中医辨证,针对病证的病因病机,利用药物相辅相成的配伍原理,有目的地将诸药按君、臣、佐、使的组织结构合理配伍,使方中的药物及其配伍与病证的病机丝丝入扣,使药物配伍后的综合效用与所立治法高度统一。
尽管本发明的内容已经通过上述优选实施例作了详细介绍,但应当认识到上述的描述不应被认为是对本发明的限制。在本领域技术人员阅读了上述内容后,对于本发明的多种修改和替代都将是显而易见的。因此,本发明的保护范围应由所附的权利要求来限定。
Claims (8)
1.一种用于心脑血管疾病的药物组合物,其特征在于,该药物组合物的原料包含:棋楠、当归、党参、黄芪、天麻、藏红花、丹参、红景天、远志、麦冬、绞股蓝、鳖甲、三七、川穹。
2.如权利要求1所述的用于心脑血管疾病的药物组合物,其特征在于,所述的原料按重量份数计包含:棋楠200~300份、当归20~40份、党参10~30份、黄芪20~40份、天麻10~30份、藏红花5~15份、丹参40~60份、红景天10~30份、远志10~15份、麦冬10~15份、绞股蓝25~30份、鳖甲10~30份、三七20~40份、川穹40~60份。
3.如权利要求2所述的用于心脑血管疾病的药物组合物,其特征在于,所述的原料按重量计包含:棋楠2500g、当归300g、党参200g、黄芪300g、天麻200g、藏红花100g、丹参500g、红景天200g、远志120g、麦冬120g、绞股蓝260g、鳖甲200g、三七300g、川穹500g。
4.一种如权利要求1~3中任意一项所述的用于心脑血管疾病的药物组合物的用途,其特征在于,所述的药物组合物用于制备心脑血管疾病患者服用的冲剂。
5.一种如权利要求4所述的冲剂的制备方法,其特征在于,所述的方法为:按比例称量各药物,将各原料研磨破碎成粉末,然后加水浸泡,并加热萃取,再将药液通过浓缩提纯去除水分,干燥得到药物颗粒,最后密封包装灭菌,作为冲剂使用。
6.如权利要求5所述的冲剂的制备方法,其特征在于,所述的研磨破碎的粒度范围为30~40目。
7.如权利要求5所述的冲剂的制备方法,其特征在于,所述的加水浸泡的时间为24小时或以上。
8.如权利要求5所述的冲剂的制备方法,其特征在于,所述的冲剂采用温水冲服。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111154481.8A CN113786459A (zh) | 2021-09-29 | 2021-09-29 | 一种用于心脑血管疾病的药物组合物及其制备方法与用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111154481.8A CN113786459A (zh) | 2021-09-29 | 2021-09-29 | 一种用于心脑血管疾病的药物组合物及其制备方法与用途 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113786459A true CN113786459A (zh) | 2021-12-14 |
Family
ID=78877785
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111154481.8A Pending CN113786459A (zh) | 2021-09-29 | 2021-09-29 | 一种用于心脑血管疾病的药物组合物及其制备方法与用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113786459A (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114344408A (zh) * | 2022-01-19 | 2022-04-15 | 国鼎山河(海南)医药集团有限责任公司 | 一种用于心脏疾病疏通心梗的组合物及其用途与制备方法 |
CN114404526A (zh) * | 2022-02-07 | 2022-04-29 | 国鼎山河(海南)医药集团有限责任公司 | 一种用于脑梗和脑血管疾病的组合物及其用途与制备方法 |
CN117085091A (zh) * | 2023-06-06 | 2023-11-21 | 深圳市鼎昌盛生物科技有限公司 | 一种治疗心血管疾病的中药组合物 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104367656A (zh) * | 2014-11-10 | 2015-02-25 | 成都果睿医药科技有限公司 | 一种含有山楂叶的治疗心脑血管疾病的药物组合物 |
CN104491053A (zh) * | 2014-12-03 | 2015-04-08 | 唐逍 | 一种防治心脑血管疾病中药制剂及其制备方法 |
CN106937991A (zh) * | 2017-02-14 | 2017-07-11 | 四川双鑫生物科技有限公司 | 一种用于治疗心脑血管疾病的汤剂药物及其制备方法 |
CN113117017A (zh) * | 2019-12-30 | 2021-07-16 | 睿特环中医药科技发展有限公司 | 一种治疗心脑血管疾病的中药组合物及其制备方法 |
-
2021
- 2021-09-29 CN CN202111154481.8A patent/CN113786459A/zh active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104367656A (zh) * | 2014-11-10 | 2015-02-25 | 成都果睿医药科技有限公司 | 一种含有山楂叶的治疗心脑血管疾病的药物组合物 |
CN104491053A (zh) * | 2014-12-03 | 2015-04-08 | 唐逍 | 一种防治心脑血管疾病中药制剂及其制备方法 |
CN106937991A (zh) * | 2017-02-14 | 2017-07-11 | 四川双鑫生物科技有限公司 | 一种用于治疗心脑血管疾病的汤剂药物及其制备方法 |
CN113117017A (zh) * | 2019-12-30 | 2021-07-16 | 睿特环中医药科技发展有限公司 | 一种治疗心脑血管疾病的中药组合物及其制备方法 |
Non-Patent Citations (2)
Title |
---|
梅全喜等: "沉香的药用历史、品种、产地研究应用浅述", 《中国中医药现代远程教育》 * |
牛世勇等: "《沉香鉴定、收藏与品玩》", 31 August 2017, 文化发展出版社 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114344408A (zh) * | 2022-01-19 | 2022-04-15 | 国鼎山河(海南)医药集团有限责任公司 | 一种用于心脏疾病疏通心梗的组合物及其用途与制备方法 |
CN114404526A (zh) * | 2022-02-07 | 2022-04-29 | 国鼎山河(海南)医药集团有限责任公司 | 一种用于脑梗和脑血管疾病的组合物及其用途与制备方法 |
CN117085091A (zh) * | 2023-06-06 | 2023-11-21 | 深圳市鼎昌盛生物科技有限公司 | 一种治疗心血管疾病的中药组合物 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111544543A (zh) | 一种具有清肺、解烟毒及解酒益肝功能的组合物 | |
CN113786459A (zh) | 一种用于心脑血管疾病的药物组合物及其制备方法与用途 | |
CN110141644A (zh) | 一种用于改善视力的药物组合物及其制备方法与用途 | |
CN113730479A (zh) | 一种具有保健功能的组合物及其制备方法与用途 | |
CN104998061A (zh) | 一种治疗宫寒不孕的中药配方及其制备方法 | |
CN107744569A (zh) | 一种具有养发、生发功效的精华液及其制备方法 | |
CN104524228A (zh) | 一种治疗心脾两虚型心律失常的中药及制备方法 | |
CN114099626A (zh) | 一种用于人体保健的多功能组合物及其制备方法与用途 | |
CN104740216A (zh) | 一种用于治疗冠心病心绞痛的中药 | |
CN105232958B (zh) | 一种用于制备治疗重症肌无力的药物的中药组合物 | |
CN103690811A (zh) | 一种降血压、预防头昏眼花的中药口服液及其制备方法 | |
CN113332390A (zh) | 一种补肝肾的中药组合物及其制备方法 | |
CN113663050A (zh) | 用于调节痛经和女性内分泌的组合物及其制备方法与用途 | |
CN114344434B (zh) | 一种治疗肺结节的中药组合物及其制备方法 | |
CN110917302A (zh) | 一种治疗糖尿病的中药及其制备方法 | |
CN108714167B (zh) | 一种治疗白癜风的中药外用制剂及其制备方法 | |
CN108704040B (zh) | 一种中药组合物及其应用 | |
CN108057088B (zh) | 一种治疗乳腺疾病的中草药组合物及其制备方法 | |
CN107335018B (zh) | 一种用于老年病患者脾肾两虚兼夹血瘀的调补药物及其制备方法 | |
CN106139105A (zh) | 一种治疗尿毒症的中药配方 | |
CN116509946A (zh) | 一种治疗前列腺增生的中药复方及其制备方法 | |
CN113876884A (zh) | 一种延年益寿的药物组合物及其制备方法与用途 | |
CN105362714A (zh) | 用于治疗口腔癌的中药组合物 | |
CN114344408A (zh) | 一种用于心脏疾病疏通心梗的组合物及其用途与制备方法 | |
CN105079198A (zh) | 一种用于治疗乳腺增生的中药组合物、口服剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20211214 |